Frontier Capital Management CO LLC Natera, Inc. Transaction History

Frontier Capital Management CO LLC

$10 Billion
Q3 2025

A detailed history of Frontier Capital Management CO LLC transactions in Natera, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 369,014 shares of NTRA stock, worth $75.4 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

369,014

Previous 384,964 4.14%

Holding current value

$75.4 Million

Previous $65 Million 8.66%

% of portfolio

0.59%

Previous 0.66%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$133.66 - $181.11 $2.13 Million - $2.89 Million	-15,950 Reduced 4.14%	369,014 $59.4 Million
Q2 2025 Aug 14, 2025	SELL	$132.23 - $171.87 $1.81 Million - $2.36 Million	-13,712 Reduced 3.44%	384,964 $65 Million
Q1 2025 May 15, 2025	SELL	$132.63 - $177.0 $58.6 Million - $78.2 Million	-441,990 Reduced 52.58%	398,676 $56.4 Million
Q4 2024 Feb 14, 2025	SELL	$117.67 - $174.0 $22.2 Million - $32.8 Million	-188,612 Reduced 18.32%	840,666 $133 Million
Q3 2024 Nov 14, 2024	SELL	$97.75 - $129.67 $6.09 Million - $8.08 Million	-62,338 Reduced 5.71%	1,029,278 $131 Million

Q2 2024 Aug 14, 2024	SELL	$85.28 - $112.6 $4.5 Million - $5.94 Million	-52,717 Reduced 4.61%	1,091,616 $118 Million
Q1 2024 May 15, 2024	BUY	$59.21 - $92.9 $10.7 Million - $16.8 Million	181,105 Added 18.8%	1,144,333 $105 Million
Q4 2023 Feb 14, 2024	SELL	$37.55 - $62.64 $2.02 Million - $3.38 Million	-53,898 Reduced 5.3%	963,228 $60.3 Million
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $13.1 Million - $18.9 Million	-301,674 Reduced 22.87%	1,017,126 $45 Million
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $7.51 Million - $8.8 Million	-159,448 Reduced 10.79%	1,318,800 $64.2 Million
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $44.6 Million - $71.1 Million	1,220,298 Added 473.08%	1,478,248 $82.1 Million
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $3.78 Million - $5.3 Million	-110,656 Reduced 30.02%	257,950 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $19.3 Million - $29.6 Million	-521,846 Reduced 58.6%	368,606 $16.2 Million
Q2 2022 Jul 20, 2022	SELL	$28.13 - $44.54 $1.94 Million - $3.07 Million	-68,874 Reduced 7.18%	890,452 $31.6 Million
Q1 2022 Apr 14, 2022	BUY	$30.32 - $91.33 $12.7 Million - $38.3 Million	418,933 Added 77.52%	959,326 $39 Million
Q4 2021 Jan 19, 2022	SELL	$86.26 - $119.0 $21.2 Million - $29.2 Million	-245,635 Reduced 31.25%	540,393 $50.5 Million
Q3 2021 Oct 19, 2021	SELL	$100.17 - $126.36 $21.5 Million - $27.1 Million	-214,607 Reduced 21.45%	786,028 $87.6 Million
Q2 2021 Aug 09, 2021	BUY	$86.05 - $119.72 $47.9 Million - $66.6 Million	556,085 Added 125.09%	1,000,635 $114 Million
Q1 2021 May 13, 2021	SELL	$91.47 - $124.36 $6.94 Million - $9.43 Million	-75,857 Reduced 14.58%	444,550 $45.1 Million
Q4 2020 Jan 19, 2021	SELL	$66.66 - $111.74 $9.78 Million - $16.4 Million	-146,654 Reduced 21.99%	520,407 $51.8 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $1.55 Million - $2.46 Million	33,796 Added 5.34%	667,061 $48.2 Million
Q2 2020 Jul 17, 2020	SELL	$26.36 - $49.86 $4.07 Million - $7.7 Million	-154,349 Reduced 19.6%	633,265 $31.6 Million
Q1 2020 Apr 16, 2020	BUY	$17.27 - $40.17 $456,946 - $1.06 Million	26,459 Added 3.48%	787,614 $23.5 Million
Q4 2019 Feb 14, 2020	SELL	$32.1 - $40.4 $3.48 Million - $4.38 Million	-108,463 Reduced 12.47%	761,155 $25.6 Million
Q3 2019 Nov 14, 2019	BUY	$25.38 - $34.89 $18.5 Million - $25.4 Million	728,830 Added 517.68%	869,618 $28.5 Million
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $2.5 Million - $3.88 Million	140,788 New	140,788 $3.88 Million

Others Institutions Holding NTRA

# of Institutions

752

Shares Held

127M

Call Options Held

1.13M

Put Options Held

449K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $19.8B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account

Frontier Capital Management CO LLC Natera, Inc. Transaction History